Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is assessing the efficacy and safety of Debio 4126 in adults with acromegaly who were previously treated with somatostatin analogs; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Debio 4126

Snippet

Sponsor: Debiopharm International SA | Conditions: Acromegaly | Phase 3 | Status: RECRUITING